N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide

Term ID

CHEBI:143112

Synonyms

AKI00000062a
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide
N-[5-(1-benzyltriazol-4-yl)-1H-indazol-3-yl]-2-(dimethylamino)acetamide

Definition

A member of the class of indazoles that is 1H-indazole which is substituted by a (N,N-dimethylglycyl)nitrilo group and a 1-benzyl-1H-1,2,3-triazol-4-yl group at positions 3 and 5, respectively. It is a GSK-3beta, CDK1, CDK2, CSNK1G2 and CLK4 kinase inhibitor.

References

Patent:US9163007

Ontology

ChEBI ( EBI )

Relationships

is a type of: benzenes indazoles secondary carboxamide tertiary amino compound triazoles

benzenes indazoles secondary carboxamide tertiary amino compound triazoles Show first 5 Terms
has_role: EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor EC 2.7.11.22 (cyclin-dependent kinase) inhibitor EC 2.7.11.26 (tau-protein kinase) inhibitor

EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor EC 2.7.11.22 (cyclin-dependent kinase) inhibitor EC 2.7.11.26 (tau-protein kinase) inhibitor Show first 5 Terms

Phenotype

Phenotype resulting from N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide

Phenotype where environments contain N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide

Phenotype modified by environments containing N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide

Human Disease Model